This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jun. 5, 2013


 



Promising new cancer drugs empower the body's own defenses
The New York Times
The early success of a new class of cancer drugs, revealed in test results released recently, has raised hope among the world's top cancer specialists that they may be on the verge of an important milestone in the fight against the disease.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Advertisement


Report: 83 percent of cancer doctors face oncology drug shortages
The Medical News
Eighty-three percent of cancer doctors report that they've faced oncology drug shortages, and of those, nearly all say that their patients' treatment has been impacted, according to a study from researchers at the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania that will be presented at the 2013 annual American Society of Clinical Oncology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


No longer a death sentence, cancer now has care gaps
Bloomberg
After Teresa Levitch underwent successful chemotherapy and radiation for the cancer attacking her immune system, she believed her health problems were over. Now she knows better. For more than 10 years after her treatment, she felt pain and muscle fatigue in her upper body, and her range of motion was limited.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Are you an Average or Above Average Doctor?

See how you match up against your peers in several financial categories with the MediGain Benchmark report. How does your compensation compare with other physicians in your specialty? What about your Charges and Reimbursements? Let us provide you with the insights into your practice that will mean more CASH for you.
 


More breast cancer trials for younger patients
Medical News Today
The poorer survival rates of younger breast cancer patients could be a result of insufficient clinical trials for this age group. This was a conclusion of a major new Cancer Research UK study published online recently in the Journal of the National Cancer Institute.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Funding cuts threaten modernization of cancer research
Medscape Medical News
The time has never been better for making advances in medical research, and significant progress has been made toward modernizing clinical cancer research. However, an expert panel warned that these advances are in danger of stagnating as a result of the recent across-the-board federal budget cuts.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Oncology OnTrack Supports Nurse Navigation
Oncology OnTrack is used to navigate patients with any cancer type from screening to diagnosis, treatment and survivorship, interfaces with other programs and supports accreditations.
Advertise here!

To find out how to feature your company in The CoC Brief and other advertising opportunities, contact James DeBois at 469-420-2618.
MORE


Long-term Tamoxifen gains more support
Medpage Today
A second large trial has found that for women with estrogen receptor-positive breast cancer, a decade of tamoxifen is better than stopping after 5 years.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Drug shrinks tumors in metastatic thyroid cancer
USA TODAY
There has never been an effective drug for advanced thyroid cancer. Until now. The drug, called Nexavar, doesn't cure cancer. Still, it shrank tumors in 12 percent of patients randomly assigned to take it. By comparison, less than 1 percent of tumors shrank in patients taking a placebo, or sugar pill, according to a study.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New direction for prostate cancer research a world first
Medical Xpress
Researchers at the University of Adelaide are spearheading a new direction in prostate cancer research, with the potential for new treatments of the disease. The researchers hope they will overcome a major problem that limits current treatments for metastatic prostate cancer and improve men's chances of surviving.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword PROSTATE CANCER.


Vinegar reduces cervical cancer screening mortality
Medscape Medical News
A simple screening technique using an inexpensive agent dramatically reduced deaths related to cervical cancer in a population of Indian women. Visual inspection with acetic acid or vinegar, conducted by nonmedical personnel trained to deliver basic healthcare, cut the death rate by 31 percent.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 




The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Andrew Plock, Content Editor, 469.420.2609  
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

May 29, 2013
May 22, 2013
May 15, 2013
May 8, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063